173 related articles for article (PubMed ID: 9402658)
1. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
Chisi JE; Wdzieczak-Bakala J; Riches AC
Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658
[TBL] [Abstract][Full Text] [Related]
2. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
Rousseau-Plasse A; Wdzieczak-Bakala J; Lenfant M; Ezan E; Genet R; Robinson S; Briscoe T; Melville J; Riches A
Exp Hematol; 1998 Oct; 26(11):1074-9. PubMed ID: 9766448
[TBL] [Abstract][Full Text] [Related]
3. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
4. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
5. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures.
Chisi JE; Wdzieczak-Bakala J; Thierry J; Briscoe CV; Riches AC
Stem Cells; 1999; 17(6):339-44. PubMed ID: 10606162
[TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats.
Junot C; Nicolet L; Ezan E; Gonzales MF; Menard J; Azizi M
J Pharmacol Exp Ther; 1999 Dec; 291(3):982-7. PubMed ID: 10565814
[TBL] [Abstract][Full Text] [Related]
7. The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferation.
Robinson S; Lenfant M; Wdzieczak-Bakala J; Riches A
Stem Cells; 1993 Sep; 11(5):422-7. PubMed ID: 8241953
[TBL] [Abstract][Full Text] [Related]
8. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.
Chisi JE; Briscoe CV; Ezan E; Genet R; Riches AC; Wdzieczak-Bakala J
Br J Haematol; 2000 Jun; 109(3):563-70. PubMed ID: 10886205
[TBL] [Abstract][Full Text] [Related]
9. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE
Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
[TBL] [Abstract][Full Text] [Related]
10. Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
Oliveira CR; Paredes-Gamero EJ; Barbosa CM; Nascimento FD; Batista EC; Reis FC; Martins AH; Ferreira AT; Carmona AK; Pesquero JB; Tersariol IL; Araújo RC; Bincoletto C
Chem Biol Interact; 2010 Mar; 184(3):388-95. PubMed ID: 20096676
[TBL] [Abstract][Full Text] [Related]
11. Activity of acetyl-Ser-Asp-Lys-Pro (AcSDKP) on human hematopoietic progenitor cells in short-term and long-term bone marrow cultures.
Jackson JD; Ozerol E; Yan Y; Ewel C; Talmadge JE
J Hematother Stem Cell Res; 2000 Aug; 9(4):489-96. PubMed ID: 10982247
[TBL] [Abstract][Full Text] [Related]
12. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
[TBL] [Abstract][Full Text] [Related]
13. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Michaud A; Williams TA; Chauvet MT; Corvol P
Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of analogues of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of primitive haematopoietic cell proliferation.
Thierry J; Grillon C; Gaudron S; Potier P; Riches A; Wdzieczak-Bakala J
J Pept Sci; 2001 May; 7(5):284-93. PubMed ID: 11428549
[TBL] [Abstract][Full Text] [Related]
16. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of the tetrapeptide N-Ac-Ser-Asp-Lys-Pro (AcSDKP), an inhibitor of hematopoietic stem cell (CFU-S) proliferation, following in vitro incubation with hematopoietic tissues from normal and leukemic mice.
Wdzieczak-Bakala J; Grillon C; Robinson S; Riches A; Carde P; Lenfant M
Bull Cancer; 1993 May; 80(5):391-6. PubMed ID: 8173192
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
Azizi M; Junot C; Ezan E; Ménard J
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1066-9. PubMed ID: 11903317
[TBL] [Abstract][Full Text] [Related]
19. The tetrapeptide AcSDKP, a physiological inhibitor of normal cell proliferation, reduces the S phase entry of continuous cell lines.
Volkov L; Quéré P; Coudert F; Comte L; Praloran V
Exp Cell Res; 1996 Feb; 223(1):112-6. PubMed ID: 8635482
[TBL] [Abstract][Full Text] [Related]
20. Role of liquid membrane phenomenon in biological actions of ACE inhibitors, captopril and lisinopril.
Nagappa AN; Patil RT; Pandi V; Ziauddin K
Indian J Biochem Biophys; 2001 Dec; 38(6):412-6. PubMed ID: 11989672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
